证券代码：300409 证券简称：道氏技术 公告编号：2026-006 广东道氏技术股份有限公司 2026年第一次临时股东会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东会没有出现否决议案的情形。 2、本次股东会没有涉及变更前次股东会已通过的决议。 3、本次股东会采取现场投票和网络投票相结合的方式召开。 一、会议召开情况 1、会议召集人：广东道氏技术股份有限公司（以下简称"公司"）董事会 2、会议召开日期与时间： （1）现场会议召开时间：2026 年 1 月 15 日（星期四）14:00 （2）网络投票时间：2026 年 1 月 15 日 其中，通过深圳证券交易所交易系统进行网络投票的具体时间为：2026 年 1 月 15 日 9:15-9:25、9:30-11:30，13:00-15:00；通过深圳证券交易所互联网投票系 统投票的具体时间为 2026 年 1 月 15 日 9:15 至 15:00 期间的任意时间。 3、会议召开地点：广东省佛山市禅城区南庄镇怡水三路 1 号 1 座佛山市道 氏科技有限公司 5 楼会议室。 ...

关于广东道氏技术股份有限公司 2026 年第一次临时股东会的 法律意见书 二〇二六年一月 | 四、结论意见 4 | | --- | 北京市中伦（深圳）律师事务所 北京市中伦（深圳）律师事务所 关于广东道氏技术股份有限公司 2026 年第一次临时股东会的 法律意见书 致：广东道氏技术股份有限公司 根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民 共和国证券法》以及中国证券监督管理委员会（以下简称"中国证监会"）发布 的《上市公司股东会规则》的规定，北京市中伦（深圳）律师事务所（以下简称 "本所"）接受广东道氏技术股份有限公司（以下简称"公司"）的委托，指派 本所律师列席公司 2026 年第一次临时股东会（以下简称"本次股东会"），本 所指派的律师通过现场和实时视频方式对本次股东会的相关事项进行见证并出 具本法律意见书。 为出具本法律意见书，本所律师审查了公司提供的包括但不限于如下相关文 件： 1. 公司现行有效的公司章程； 2. 公司于 2025 年 12 月 31 日刊登于巨潮资讯网（www.cninfo.com.cn）的第 六届董事会 2025 年第 15 次会议决议； 3. 公司于 20 ...

Market Overview - The battery sector experienced a decline of 0.38% on the previous trading day, with Huasheng Lithium leading the drop [1] - The Shanghai Composite Index closed at 4126.09, down 0.31%, while the Shenzhen Component Index closed at 14248.6, up 0.56% [1] Top Gainers in Battery Sector - Yihuatong (688339) saw a closing price of 32.22, with a significant increase of 12.50% and a trading volume of 265,400 shares, totaling a transaction value of 848 million [1] - Fulim Precision (300432) closed at 20.17, up 7.92%, with a trading volume of 2,140,700 shares [1] - Xianhui Technology (688155) closed at 77.32, increasing by 6.35% with a trading volume of 77,000 shares [1] Top Losers in Battery Sector - Washington Electric (688353) closed at 104.69, down 5.67%, with a trading volume of 119,700 shares and a transaction value of 128 million [2] - Tianji Co. (002759) closed at 42.42, decreasing by 3.83% with a trading volume of 895,600 shares [2] - Daoshi Technology (300409) closed at 33.30, down 3.06%, with a trading volume of 1,703,200 shares [2] Capital Flow Analysis - The battery sector saw a net outflow of 2.89 billion in main funds, while retail investors had a net inflow of 2.93 billion [2] - The main funds showed a net inflow in several companies, including 32.5 million in Xianhui Technology (300450) and 181 million in Penghui Energy (300438) [3] - Retail investors had significant net inflows in companies like Yihuatong (688339) and Fulim Precision (300432), indicating a shift in investor sentiment [3]

Group 1 - The core point of the news is that Daoshi Technology's stock price increased by 5.01% to 36.07 CNY per share, with a trading volume of 3 billion CNY and a turnover rate of 12.65%, resulting in a total market capitalization of 28.216 billion CNY [1] - Daoshi Technology, established on September 21, 2007, and listed on December 3, 2014, is primarily engaged in the production and sale of building ceramic glaze materials, along with providing related technical services and product design, commercial factoring, and new energy materials [1] - The revenue composition of Daoshi Technology includes: Other 47.44%, Lithium battery materials 34.70%, Carbon materials 9.00%, and Ceramic materials 8.85% [1] Group 2 - E Fund's fund holds a significant position in Daoshi Technology, with the E Fund ChiNext Mid-cap 200 ETF (159572) holding 254,000 shares, accounting for 1% of the fund's net value, ranking as the eighth largest holding [2] - The E Fund ChiNext Mid-cap 200 ETF (159572) has a current scale of 644 million CNY, with a year-to-date return of 11.1%, ranking 566 out of 5520 in its category, and a one-year return of 57.66%, ranking 1042 out of 4203 [2]

Core Concept - The article discusses the transformative potential of AI for Science (AI4S) in reshaping China's technological landscape, emphasizing its role in enhancing foundational research efficiency and addressing critical industry challenges [3][9][10]. Group 1: AI4S Overview - AI4S represents a paradigm shift in scientific research, moving from a trial-and-error approach to a data and model-driven methodology, which is crucial for overcoming efficiency bottlenecks in foundational research [3][4]. - The integration of AI into foundational research is seen as a key factor for China's technological breakthroughs, particularly in critical sectors such as new materials, biomedicine, and semiconductors [3][9]. Group 2: Applications in New Materials - Fangda Carbon (600516.SH) and Jingtai Technology's collaboration exemplifies the application of AI4S in new materials, significantly reducing the research and development cycle from 2-3 years to 3-6 months [5]. - The partnership aims to optimize production processes and improve product yield by over 15%, showcasing the practical benefits of AI integration in traditional manufacturing [5]. Group 3: Applications in Biomedicine - Medicy (688202.SH) has redefined the drug development process through AI, achieving a significant reduction in the clinical research cycle by 40% and enhancing the accuracy of toxicity predictions to 92% [6][7]. - The company’s AI-driven platform integrates advanced technologies like Google’s AlphaFold3 and NVIDIA’s BioNeMo, allowing for rapid iteration in drug discovery and positioning China at the forefront of global pharmaceutical research [6][7]. Group 4: Applications in Semiconductors - DaoTech (300409.SZ) addresses the computational challenges in AI4S by developing specialized chips for atomic-level scientific calculations, which are essential for both materials and chip research [8]. - The establishment of the Hexi Atomic Computing Center enables a synergistic relationship between chip development and materials design, enhancing the efficiency of both fields [8]. Group 5: Market Dynamics and Future Outlook - The success of AI4S in China is attributed to a combination of industry demand, technological innovation, and supportive government policies, which collectively foster a conducive environment for AI integration in foundational research [9]. - Despite challenges such as data scarcity and talent shortages, AI4S presents unprecedented opportunities for China to advance in foundational research areas, potentially leading to a shift from a follower to a leader in global technology innovation [9][10].

Group 1: Market Trends and Developments - The brain-computer interface (BCI) sector is transitioning from clinical validation to commercial scalability, with 2026 expected to be a pivotal year for industrialization [2] - China's BCI market is projected to grow from 3.2 billion yuan in 2024 to 5.58 billion yuan in 2027, reflecting a compound annual growth rate of approximately 20% [2] - Global BCI market is anticipated to exceed 40 billion USD by 2030 [2] Group 2: Company Innovations and Collaborations - Yingkang Life has developed a comprehensive management solution for Parkinson's treatment using BCI technology, having completed over 20 deep brain stimulation surgeries [2] - Cheng Yi Tong's recent patent for "brainwave acquisition devices" is expected to enhance its core technology and market share in the BCI field [3] - Entropy Technology plans to launch a prototype BCI product by March 2026, focusing on commercial applications [3] - Yingqu Technology collaborates with various partners to develop BCI-related products, including brainwave monitoring headbands and rehabilitation robots [4] - Hanwei Technology has made breakthroughs in non-invasive flexible BCI materials, although commercial applications remain uncertain [5] - Daoshi Technology has strategically invested in Qiangnao Technology to enhance its capabilities in BCI applications across medical rehabilitation and education [6] - Sanbo Brain Science is advancing its "North Brain No. 2" project, focusing on flexible microelectrode technology for clinical applications [7] - Meihua Medical is a strategic partner in the cochlear implant sector, which is a significant application of BCI technology [7] Group 3: Investment and Strategic Partnerships - Leidi Ke has acquired a 20.41% stake in Aoyi Technology, which specializes in both BCI and robotics, enhancing its capabilities in the medical and health sectors [9] - Lihua Science and Technology's subsidiary, Weiling Medical, is developing a fully implanted wireless BCI system [10] - Guiyan Biotech is exploring precious metal materials for BCI applications, with some products in the experimental stage [11]

12日，A股全线飙升，沪指午后涨超1%，创业板指涨近2%，北证50指数大涨超5%；港股亦走高，恒生 指数涨超1%，恒生科技指数涨超3%。 具体来看，两市股指早盘震荡上扬，午后再度攀升，沪指涨超1%，续创逾10年新高；创业板指逼近 3400点，创4年新高。截至收盘，沪指涨1.09%报4165.29点，续创逾10年新高；深证成指、创业板指涨 近2%，北证50指数涨5.35%，沪深北三市合计成交约3.64万亿元，突破前期高点，创历史新纪录。 全A超4100股飘红，逾200股涨停。AI应用概念集体爆发，万兴科技（300624）、海天瑞声、昆仑万维 （300418）等涨停，星环科技尾盘亦涨停续创新高；商业航天概念热度不减，邵阳液压（301079）4日 大涨超100%，创历史新高；天力复合、铂力特、理工导航等均创新高；脑机接口概念午后拉升，道氏 技术（300409）20%涨停，倍益康、爱朋医疗（300753）等涨超10%。此外，16倍大牛股天普股份 （605255）复牌跌停。 脑机接口概念活跃 脑机接口概念盘中强势拉升，截至收盘，道氏技术20%涨停，创历史新高，熵基科技（301330）涨超 17%亦创新高，倍益康、爱朋医 ...

12日，A股全线飙升，沪指午后涨超1%，创业板指涨近2%，北证50指数大涨超5%；港股亦走 高，恒生指数涨超1%，恒生科技指数涨超3%。 全A超4100股飘红，逾200股涨停。AI应用概念集体爆发，万兴科技、海天瑞声、昆仑万维等涨 停，星环科技尾盘亦涨停续创新高；商业航天概念热度不减，邵阳液压4日大涨超100%，创历史 新高；天力复合、铂力特、理工导航等均创新高；脑机接口概念午后拉升，道氏技术20%涨停， 倍益康、爱朋医疗等涨超10%。此外，16倍大牛股天普股份复牌跌停。 值得注意的是，今日A股市场共有4只个股成交额超过200亿元，其中蓝色光标（300058）全日成 交235.9亿元，位居A股成交额首位。 AI应用概念火爆 AI应用概念盘中集体爆发，个股掀涨停潮。截至收盘，众诚科技、星图测控、流金科技30%涨 停，蓝色光标、易点天下、万兴科技、海天瑞声、昆仑万维、值得买等均涨停。 | 代码 | 名称 | � | 涨幅% | 现价 | 涨跌 | 买价 | 卖价 | 总量 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 920207 父诚科技 ...

Market Performance - The Shanghai Composite Index rose by 1.09% to close at 4165.29 points, while the Shenzhen Component Index increased by 1.75% to 14366.91 points, and the ChiNext Index gained 1.82% to 3388.34 points [1] - The North Stock 50 surged by 5.35% to 1605.77 points, with the total market turnover reaching 36,445 billion yuan, an increase of 4,922 billion yuan compared to the previous day, marking a historical high [1] Sector Highlights - The AI application sector showed significant activity, with stocks such as Yidian Tianxia (301171), Zhidema (300785), and Kunlun Wanwei (300418) hitting the 20% daily limit up, while companies like Liou Co. (002131) and Vision China (000681) also reached the limit [1] - The commercial aerospace sector strengthened, with Xingtou Measurement and Control hitting a 30% limit up, and Tianyin Machinery (300342) and Ligong Navigation also reaching the 20% limit up [1] - The brain-computer interface sector continued to perform well in the afternoon, with Daoshi Technology (300409) hitting a 20% limit up, alongside Yanshan Technology (002195) and Haige Communication (002465) [1] - The insurance sector experienced a correction, with China Ping An and China Pacific Insurance (601601) both declining over 2% [1]

脑机接口概念持续走强，南京熊猫6天5板，道氏技术"20cm"涨停，创新医疗、诚益通、三博脑科、翔 宇医疗、美好医疗、伟思医疗跟涨。 脑机接口概念持续走强，南京熊猫6天5板，道氏技术"20cm"涨停，创新医疗、诚益通、三博脑科、翔 宇医疗、美好医疗、伟思医疗跟涨。 ...